Dual-Vector Tachycardia Detection Algorithm for SVT and VT Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardioverter defibrillators (ICDs) face challenges in accurately distinguishing between supraventricular tachycardia (SVT) and ventricular tachycardia (VT), leading to inappropriate therapy delivery and battery inefficiency due to the similarity in tachycardia cycle lengths and the need for precise discrimination to apply the most effective treatment.
Innovation Solution
The implementation of a tachycardia detection algorithm using dual-vector EGM sensing to differentiate between SVT and VT by analyzing heart rate variability and morphology, allowing for beat-by-beat evidence accumulation and therapy selection based on specific rules and morphology scores.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional single-vector sensing is used for tachycardia detection, then the device complexity is low, but the measurement precision of tachycardia classification deteriorates leading to inaccurate SVT/VT discrimination
Solution Approach 1:
The patent divides the sensing function into multiple independent sensing vectors (first sensing vector and second sensing vector), each capturing electrical signals from different spatial orientations. This segmentation allows the system to analyze morphology differences across vectors to accurately discriminate between SVT and VT, resolving the contradiction by trading increased device complexity for significantly improved measurement precision in tachycardia classification.
2Reliability
If high-voltage cardioversion shocks are delivered to terminate tachycardia, then the therapy effectiveness is high, but the loss of energy increases and patient comfort deteriorates
Solution Approach 1:
The patent implements preliminary tachycardia classification using morphology analysis before delivering therapy. By accurately identifying whether the tachycardia is SVT or VT in advance, the system can select appropriate therapies - using low-energy anti-tachycardia pacing for SVT and reserving high-voltage shocks for confirmed VT cases. This preliminary discrimination action prevents unnecessary high-energy shock delivery, thereby reducing battery consumption while maintaining effective treatment for true VT cases.
3Reliability
If high-voltage cardioversion shocks are delivered to terminate tachycardia, then the therapy effectiveness is high, but the object-affected harmful factors increase due to patient pain
Solution Approach 1:
The patent introduces morphology analysis as an intermediary diagnostic step between tachycardia detection and therapy delivery. This intermediary process accurately distinguishes between SVT and VT, enabling the system to use gentler anti-tachycardia pacing therapies for SVT cases instead of immediately applying painful high-voltage shocks. The intermediary classification mechanism thereby reduces harmful patient discomfort while preserving shock therapy effectiveness for genuine VT cases that require it.
4Productivity
If aggressive shock therapy is used as default treatment, then the productivity of arrhythmia termination is high, but the loss of time increases due to unnecessary shock delivery and subsequent monitoring
Solution Approach 1:
The patent performs preliminary morphology-based tachycardia classification before initiating therapy delivery. By pre-identifying SVT versus VT using dual-vector sensing and morphology comparison, the system可以避免 unnecessary shock delivery for SVT cases and proceed directly to appropriate pacing therapies. This preliminary action eliminates wasted time from delivering ineffective shocks and subsequent post-shock monitoring, thereby improving overall arrhythmia termination productivity without compromising treatment effectiveness.
Data Source
AI summary
A medical device and associated method for discriminating cardiac events includes sensing a cardiac signal spatially located across approximately a full duration of a predetermined sensing window. A match score is determined corresponding to the sensed cardiac signal. A beat feature of multiple beat features across less than the full duration of the sensing window is determined, the beat feature being selected from the multiple beat features in response to the match score. Cardiac event evidence is accumulated in response to the match score and the determined beat feature, and cardiac events are discriminated in response to the accumulated cardiac evidence.